Ludwig Cancer Research engages leading scientists and clinicians in an integrated effort to understand and confront the challenge of cancer. The Oxford Branch is based at the University of Oxford, UK and benefits from excellent links with the global Ludwig Cancer Research and local Oxford research communities.
Ludwig Oxford Branch researchers are investigating all stages of cancer, from the risk of disease through to new treatment opportunities. Our research groups are interested in the signalling pathways that influence cancer initiation and progression, with a focus on infection, inflammation and cancer epigenetics. We aim to advance cancer prevention, early diagnosis and effective treatment. Find out more about the Ludwig Oxford research groups.
News
Publications
The double-edged nature of antibody bivalency: mathematical and experimental analysis of cell surface antigen occupancy and opsonization
Journal article
Heirene L. et al, (2026), mAbs, 18
Epigenetic modulation of stromal cell states underpins pathological tissue niches in Crohn’s disease
Journal article
Koplev S. et al, (2026), Nature Immunology, 27, 1954 - 1968
Characterising Hepatitis D Virus in the UK From 2011 to 2021.
Journal article
Simmons R. et al, (2026), Journal of viral hepatitis, 33
Seminars
